A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries

Phase 4 Completed 47 enrolled Vertex Pharmaceuticals Incorporated

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effectiveness, safety, and tolerability of SUZ for acute pain after laparoscopic procedures of the intraperitoneal or retroperitoneal cavities or arthroscopic orthopedic procedures.

Timeline

Start: 2025-03-27
Primary completion: 2025-10-27
Completion: 2025-11-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Suzetrigine	Small molecule	—	Oral

Indications

No indication recorded.